Literature DB >> 23975514

Potential applications of gut microbiota to control human physiology.

Ozgün Candan Onarman Umu1, Marije Oostindjer, Phillip B Pope, Birger Svihus, Bjørg Egelandsdal, Ingolf F Nes, Dzung B Diep.   

Abstract

The microorganisms living in our gut have been a black box to us for a long time. However, with the recent advances in high throughput DNA sequencing technologies, it is now possible to assess virtually all microorganisms in our gut including non-culturable ones. With the use of powerful bioinformatics tools to deal with multivariate analyses of huge amounts of data from metagenomics, metatranscriptomics, metabolomics, we now start to gain some important insights into these tiny gut inhabitants. Our knowledge is increasing about who they are, to some extent, what they do and how they affect our health. Gut microbiota have a broad spectrum of possible effects on health, from preventing serious diseases, improving immune system and gut health to stimulating the brain centers responsible for appetite and food intake control. Further, we may be on the verge of being capable of manipulating the gut microbiota by diet control to possibly improve our health. Diets consisting of different components that are fermentable by microbiota are substrates for different kinds of microbes in the gut. Thus, diet control can be used to favor the growth of some selected gut inhabitants. Nowadays, the gut microbiota is taken into account as a separate organ in human body and their activities and metabolites in gut have many physiological and neurological effects. In this mini-review, we discuss the diversity of gut microbiota, the technologies used to assess them, factors that affect microbial composition and metabolites that affect human physiology, and their potential applications in satiety control via the gut-brain axis.

Entities:  

Mesh:

Year:  2013        PMID: 23975514     DOI: 10.1007/s10482-013-0008-0

Source DB:  PubMed          Journal:  Antonie Van Leeuwenhoek        ISSN: 0003-6072            Impact factor:   2.271


  8 in total

1.  Resistant starch diet induces change in the swine microbiome and a predominance of beneficial bacterial populations.

Authors:  Özgün C O Umu; Jeremy A Frank; Jonatan U Fangel; Marije Oostindjer; Carol Souza da Silva; Elizabeth J Bolhuis; Guido Bosch; William G T Willats; Phillip B Pope; Dzung B Diep
Journal:  Microbiome       Date:  2015-04-16       Impact factor: 14.650

Review 2.  Does Whole Grain Consumption Alter Gut Microbiota and Satiety?

Authors:  Danielle N Cooper; Roy J Martin; Nancy L Keim
Journal:  Healthcare (Basel)       Date:  2015-05-29

Review 3.  Modulation of the gut microbiota by prebiotic fibres and bacteriocins.

Authors:  Özgün C O Umu; Knut Rudi; Dzung B Diep
Journal:  Microb Ecol Health Dis       Date:  2017-01-01

4.  Gut microbiota profiling in Norwegian weaner pigs reveals potentially beneficial effects of a high-fiber rapeseed diet.

Authors:  Özgün Candan Onarman Umu; Aud Kari Fauske; Caroline Piercey Åkesson; Marta Pérez de Nanclares; Randi Sørby; Charles McLean Press; Margareth Øverland; Henning Sørum
Journal:  PLoS One       Date:  2018-12-20       Impact factor: 3.240

5.  Rapeseed-based diet modulates the imputed functions of gut microbiome in growing-finishing pigs.

Authors:  Özgün Candan Onarman Umu; Liv Torunn Mydland; Margareth Øverland; Charles McLean Press; Henning Sørum
Journal:  Sci Rep       Date:  2020-06-10       Impact factor: 4.379

6.  Cranberry (Vaccinium macrocarpon) dietary supplementation and fecal microbiota of Wistar rats.

Authors:  Rayane Chettaoui; Gilles Mayot; Loris De Almeida; Patrick Di Martino
Journal:  AIMS Microbiol       Date:  2021-06-30

Review 7.  Metagenomic search strategies for interactions among plants and multiple microbes.

Authors:  Ulrich Melcher; Ruchi Verma; William L Schneider
Journal:  Front Plant Sci       Date:  2014-06-11       Impact factor: 5.753

8.  The Potential of Class II Bacteriocins to Modify Gut Microbiota to Improve Host Health.

Authors:  Özgün C O Umu; Christine Bäuerl; Marije Oostindjer; Phillip B Pope; Pablo E Hernández; Gaspar Pérez-Martínez; Dzung B Diep
Journal:  PLoS One       Date:  2016-10-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.